1 min Economy / FinanceBiontech to Take Over Curevac in $5.5 Billion Deal Biontech Acquires Curevac in a Move to Strengthen mRNA-Based Cancer Immunotherapy Research and Development In a bid to…June 12, 2025 Read More
